NovoCure Limited Banner Image

NovoCure Limited

  • Ticker NVCR
    Exchange NASDAQ More
  • Industry Medical Laboratories & Research More
  • Sector Healthcare More
NovoCure Limited Logo Image
  • 201-500 Employees
  • Based in Portsmouth, New Hampshire
Novocure is an oncology company developing a profoundly different cancer treatment centered on a proprietary therapy called TTFields, the use of electric fields tuned to specific frequencies to disrupt solid tumor cancer cell division. Novocure’s commercialized product, Optune, is approved for the treatment of adult patients with glioblastoma.
4.8 / 5.0 (165)

NovoCure Limited reports have an aggregate usefulness score of 4.8 based on 165 reviews.

NovoCure Limited

Most Recent Annual Report

NovoCure Limited
MOST RECENT 2022 Annual Report and Form 10K

NovoCure Limited does not currently have any hardcopy reports on AnnualReports.com. Click the button below to request a report when hardcopies become available.

Request Information

Older/Archived Annual Reports

NovoCure Limited Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!